-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation